Indivior Pharmaceuticals, Inc. Common Stock (INDV) is a publicly traded Healthcare sector company. As of May 20, 2026, INDV trades at $38.04 with a market cap of $4.32B and a P/E ratio of 22.16. INDV moved +2.91% today. Year to date, INDV is +3.53%; over the trailing twelve months it is +216.69%. Its 52-week range spans $7.33 to $41.00. Analyst consensus is strong buy with an average price target of $50.67. Rallies surfaces INDV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for INDV combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $38.04 |
| Market Cap | $4.32B |
| P/E Ratio | 22.16 |
| EPS | $1.68 |
| Dividend Yield | 0.00% |
| 52-Week High | $41.00 |
| 52-Week Low | $7.33 |
| Volume | 1.02M |
| Avg Volume | 0 |
| Revenue (TTM) | $1.24B |
| Net Income | $210.00M |
| Gross Margin | 80.23% |
4 analysts cover INDV: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.67.